HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bispectral index monitoring documents burst suppression during pentobarbital coma.

Abstract
During pentobarbital coma, electroencephalographic monitoring is used to document burst suppression (3-5 episodes of electrical activity/min). The current study evaluates the association of the bispectral index number and suppression ratio with a burst suppression pattern on electroencephalograph. The records of 7 patients (aged 2.9-14 years) who received pentobarbital for elevated intracranial pressure were retrospectively reviewed. The bispectral index number was 7 +/- 5, 14 +/- 3, and 37 +/- 12, whereas the suppression ratio was 93 +/- 7%, 75 +/- 6%, and 29 +/- 18% when the electroencephalograph showed <or= 2, 3-5, and >or= 6 bursts/min, respectively. The sensitivity and specificity of a bispectral index value of 10 to 20 were 96% and 92%, respectively, whereas the sensitivity and specificity of a suppression ratio of 65% to 85% were 89% and 88%, respectively, in demonstrating the presence of 3 to 5 bursts/min. Bispectral index monitoring may be easier to perform and may require less technical expertise to interpret.
AuthorsJoseph D Tobias
JournalJournal of intensive care medicine (J Intensive Care Med) 2008 Jul-Aug Vol. 23 Issue 4 Pg. 258-62 ISSN: 0885-0666 [Print] United States
PMID18508838 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Pentobarbital
Topics
  • Adolescent
  • Child
  • Child, Preschool
  • Coma (chemically induced)
  • Electroencephalography
  • Female
  • Humans
  • Intracranial Pressure
  • Male
  • Monitoring, Physiologic
  • Pentobarbital
  • Sensitivity and Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: